Dermal Filler Market By Type, By Gender, By Service Provider: Global Opportunity Analysis and Industry Forecast, 2021-2031

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
3.7. Patent Landscape

CHAPTER 4: DERMAL FILLER MARKET, BY TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Hyaluronic acid (HA)
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.2.4 Hyaluronic acid (HA) Dermal Filler Market by Age group
4.2.4.1 13 to 39 Market size and forecast, by region
4.2.4.2 40 to 54 Market size and forecast, by region
4.2.4.3 55 to 69 Market size and forecast, by region
4.3 Calcium Hydroxylapatite (CaHA)
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Poly L lactic Acid
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Others
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country

CHAPTER 5: DERMAL FILLER MARKET, BY GENDER
5.1 Overview
5.1.1 Market size and forecast
5.2 Male
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Female
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country

CHAPTER 6: DERMAL FILLER MARKET, BY SERVICE PROVIDER
6.1 Overview
6.1.1 Market size and forecast
6.2 Specialty and Dermatology Clinics
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Hospitals
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Others
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country

CHAPTER 7: DERMAL FILLER MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Type
7.2.2.1 North America Hyaluronic acid (HA) Dermal Filler Market by Age group
7.2.3 North America Market size and forecast, by Gender
7.2.4 North America Market size and forecast, by Service Provider
7.2.5 North America Market size and forecast, by country
7.2.5.1 U. S.
7.2.5.1.1 Market size and forecast, by Type
7.2.5.1.2 Market size and forecast, by Gender
7.2.5.1.3 Market size and forecast, by Service Provider
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Type
7.2.5.2.2 Market size and forecast, by Gender
7.2.5.2.3 Market size and forecast, by Service Provider
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Type
7.2.5.3.2 Market size and forecast, by Gender
7.2.5.3.3 Market size and forecast, by Service Provider
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Type
7.3.2.1 Europe Hyaluronic acid (HA) Dermal Filler Market by Age group
7.3.3 Europe Market size and forecast, by Gender
7.3.4 Europe Market size and forecast, by Service Provider
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Type
7.3.5.1.2 Market size and forecast, by Gender
7.3.5.1.3 Market size and forecast, by Service Provider
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Type
7.3.5.2.2 Market size and forecast, by Gender
7.3.5.2.3 Market size and forecast, by Service Provider
7.3.5.3 UK
7.3.5.3.1 Market size and forecast, by Type
7.3.5.3.2 Market size and forecast, by Gender
7.3.5.3.3 Market size and forecast, by Service Provider
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Type
7.3.5.4.2 Market size and forecast, by Gender
7.3.5.4.3 Market size and forecast, by Service Provider
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Type
7.3.5.5.2 Market size and forecast, by Gender
7.3.5.5.3 Market size and forecast, by Service Provider
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Type
7.3.5.6.2 Market size and forecast, by Gender
7.3.5.6.3 Market size and forecast, by Service Provider
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Type
7.4.2.1 Asia-Pacific Hyaluronic acid (HA) Dermal Filler Market by Age group
7.4.3 Asia-Pacific Market size and forecast, by Gender
7.4.4 Asia-Pacific Market size and forecast, by Service Provider
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 China
7.4.5.1.1 Market size and forecast, by Type
7.4.5.1.2 Market size and forecast, by Gender
7.4.5.1.3 Market size and forecast, by Service Provider
7.4.5.2 Japan
7.4.5.2.1 Market size and forecast, by Type
7.4.5.2.2 Market size and forecast, by Gender
7.4.5.2.3 Market size and forecast, by Service Provider
7.4.5.3 India
7.4.5.3.1 Market size and forecast, by Type
7.4.5.3.2 Market size and forecast, by Gender
7.4.5.3.3 Market size and forecast, by Service Provider
7.4.5.4 Australia
7.4.5.4.1 Market size and forecast, by Type
7.4.5.4.2 Market size and forecast, by Gender
7.4.5.4.3 Market size and forecast, by Service Provider
7.4.5.5 Rest of Asia-Pacific
7.4.5.5.1 Market size and forecast, by Type
7.4.5.5.2 Market size and forecast, by Gender
7.4.5.5.3 Market size and forecast, by Service Provider
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Type
7.5.2.1 LAMEA Hyaluronic acid (HA) Dermal Filler Market by Age group
7.5.3 LAMEA Market size and forecast, by Gender
7.5.4 LAMEA Market size and forecast, by Service Provider
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Type
7.5.5.1.2 Market size and forecast, by Gender
7.5.5.1.3 Market size and forecast, by Service Provider
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Type
7.5.5.2.2 Market size and forecast, by Gender
7.5.5.2.3 Market size and forecast, by Service Provider
7.5.5.3 Colombia
7.5.5.3.1 Market size and forecast, by Type
7.5.5.3.2 Market size and forecast, by Gender
7.5.5.3.3 Market size and forecast, by Service Provider
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Type
7.5.5.4.2 Market size and forecast, by Gender
7.5.5.4.3 Market size and forecast, by Service Provider

CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Players
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments

CHAPTER 9: COMPANY PROFILES
9.1 AbbVie Laboratories
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Bioxis pharmaceutical
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Cutera Inc
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Elan aesthetics Inc
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Galderma SA
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Merz Pharma GmbH and Co. KGaA
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Revance Therapeutics
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Sinclair Pharma
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Teoxane Laboratories
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Vital Esthetique Laboratories
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments

Executive Summary

According to this report, titled, 'Dermal Filler Market,'The global dermal filler market size was valued at $5,184.8 million in 2021, and is projected to reach $14,418.4 million by 2031, registering a CAGR of 10.8% from 2022 to 2031. Dermal filler is defined as a gel like substance, which is injected into the face to enhance shallow contours, plump thin lips, remove wrinkles, soften facial creases, and diminish the appearance of the scars. Hyaluronic acid is one of the most common types of dermal filler used among the population. Dermal filler is injected by the healthcare providers around the eyes, mouth, and nose. Dermal filler procedures aim to gain youthful appearance and enhance the facial features.

The factors that drive the growth of the global dermal filler market size include an increase in the prevalence of the geriatric population, technological advancements in dermal filler product, and surge in demand for anti-aging treatment. In addition, the rise in number of injectable fillers procedure in the female population, notably contributes toward the growth of the global market. According to the International Society of Aesthetic Plastic Surgery, in 2020, approximately 2.5 million hyaluronic acid procedure is conducted in the female population across the world. As per the same source, in 2020, approximately 1.3 million hyaluronic acid procedure is conducted in population of the age group between 40 to 54 years. This augments the need for dermal filler products among the geriatric population. Furthermore, market players focus on the manufacturing of advanced dermal filler for aesthetic solution. For instance, in February 2022, Merz Aesthetics, a medical aesthetics company announced the launch of Radiesse (+) Lidocaine injectable implant for deep injection to improve moderate to severe loss of jawline contour in adults over the age of 21 years. Moreover, Galderma is a dermatologist and pharmaceutical company, received approval for two aesthetic products. Thus, increase in number of dermal filler industry to manufacture dermal filler products propels the growth of the market.

In addition, in May 2020, the Food & Drug Administration (FDA) announced the approval for Restylane kysse, a new hyaluronic acid (HA) filler specifically designed and indicated to add fullness to lips and help smoothen wrinkles above the mouth. The FDA aims to enhance the availability of dermal filler product and increase the access to a wide range of dermal filler for consumers.

Moreover, rise in development of medical aesthetic industry and improvement in healthcare spending are anticipated to drive the growth of the dermal filler market. For instance, in 2021, McKinsey & Company, conducted a survey to analyze the use of dermal filler among different age group and income population. It was reported that, the population with annual income of more than $100,000 are the active users of dermal filler. In addition, the increase in the number of female population and rise in self-awareness among young population regarding the physical appearance led to the development of innovative technologies in the aesthetic sector, thereby propelling the growth of the market.

Moreover, the increase in the number of licensed medical centers is the key factor that boosts the growth of the dermal filler market analysis. The reason behind the increasing number of medical centers is attributed to surge in number of non-invasive aesthetic procedures such as dermal filler and botox. Furthermore, the rise in prevalence of skin damage and increase in geriatric female population, who are more vulnerable to wrinkle and facial line, propel the growth of the market. In addition, the rise in disposable income and increase in awareness regarding different facial aesthetic treatments among the female population fuel the dermal filler market trends.

The dermal filler market share is segmented on the basis of type, gender, service provider, and region. On the basis of type, the market is divided into hyaluronic acid (HA), calcium hydroxylapatite (CaHA), poly-L-lactic acid, and others. The others segment is further divided into polymethyl-methacrylate microspheres (PMMA) and fat face. The hyaluronic acid segment dominated the market in 2021, and this trend is expected to continue during the dermal filler market forecast period, owing to increase in number of hyaluronic acids-based dermal filler products, advancement in R&D activities in medical aesthetic industry, and rise in prevalence of early aging of the skin.

By gender, it is bifurcated into male and female. The female segment acquired the top position in the market in 2021, and this trend is expected to continue during the forecast period, owing to increase in demand for dermal filler procedures, rapidly growing emphasis on personal aesthetics among females, and rise in number of female populations conducting minimal invasive aesthetic procedure.

As per service provider, the market is classified into specialty & dermatology clinics, hospitals, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The hospitals segment led the market in 2021, and this trend is expected to continue during the forecast period, owing to increase in number of hospitals to conduct dermal filler procedures and rise in expenditure by governments to improve the healthcare industry.

North America accounted for a majority of the global dermal filler market share in 2021, and is anticipated to remain dominant during the forecast period. This is attributed to a rise in prevalence of early aging of the skin due to external environmental factors, increase in the number of approvals for dermal filler product, the presence of dermal filler industry, and development in technology for dermal filler in the region. Asia-Pacific is anticipated to witness lucrative growth, owing to increase in number of approvals for aesthetic products, the rise in geriatric populations, growth in health care expenditures, and a rise in adoption of dermal filler product.

The COVID-19 outbreak is anticipated to have a negative impact on the growth of the global dermal filler market. A number of clinics and hospitals were restructured to increase hospital capacities for patients diagnosed with COVID-19. Non-essential surgical procedures were cancelled due to the pandemic. Dermal filler procedures are non-emergency procedures that significantly hampered revenue of aesthetic companies. In addition, sudden, sharp cut in a monthly income of the population is anticipated to have a negative impact on the dermal filler market.

Key Findings of The Study

By type, the hyaluronic acid segment was the highest contributor to the market in 2021.

By gender, the male segment was the highest contributor to the market in 2021.

By service provider, the hospitals segment dominated the market in 2021, and is expected to continue this trend during the forecast period.

By region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period

Companies Mentioned

• Abbvie Laboratories
• Bioxis Pharmaceutical
• Cutera Inc.
• Elan Aesthetics Inc.
• Galderma SA
• Merz Pharma GmbH and Co. KGaA
• Revance Therapeutics
• Sinclair Pharma
• Teoxane Laboratories
• Vital Esthetique Laboratories

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

• Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
• Scientific and technical writings for product information and related preemptions
• Regional government and statistical databases for macro analysis
• Authentic news articles and other related releases for market evaluation
• Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.